awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35703167-5E7105AE-A772-4F0C-B21B-D3AB81019546
Q35703167-5E7105AE-A772-4F0C-B21B-D3AB81019546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35703167-5E7105AE-A772-4F0C-B21B-D3AB81019546
Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.
P2860
Q35703167-5E7105AE-A772-4F0C-B21B-D3AB81019546
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35703167-5E7105AE-A772-4F0C-B21B-D3AB81019546
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66f49e73972762200d706aa8f68bcf8a744d665d
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr